Scientists believe they’ve solved the mystery of why a diabetes drug introduced in 1997 caused fatal liver failure in 63 patients.
Their discovery makes it likely that similar drug-related deaths can be prevented in the future.
In 1997, troglitazone was approved for use in the United States as one of the first drugs designed to treat type 2 diabetes. It was withdrawn from the market in 2000 after 63 people died from liver failure after taking it.
Help employers find you! Check out all the jobs and post your resume.
